• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耳滴液的耳毒性:临床视角

Ototoxicity of ear drops: a clinical perspective.

作者信息

Linder T E, Zwicky S, Brändle P

机构信息

Department of Otorhinolaryngology, University Hospital Zürich, Switzerland.

出版信息

Am J Otol. 1995 Sep;16(5):653-7.

PMID:8588672
Abstract

Although experimental data confirm the presence of ototoxicity due to topical ear drops, the clinical relevance still remains debatable. Only few case reports document sensorineural hearing loss (SNHL) attributable to ototopical preparations in patients with chronic otitis media. A careful review of 134 patients charts evaluated between 1953 and 1995 for possible antibiotic related ototoxicity revealed two patients with bilateral profound SNHL attributable to excessive administration of framycetin- and polymyxin-containing ear drops in the presence of tympanic membrane perforation. Although ototopical preparations are widely used, they rarely induce SNHL. The authors emphasize patient education, application of topical ear drops using soaked gauze strips, and documentation of the patients hearing status at the beginning of the treatment regimen.

摘要

尽管实验数据证实局部用耳滴剂存在耳毒性,但临床相关性仍存在争议。仅有少数病例报告记录了慢性中耳炎患者因耳局部用药制剂导致的感音神经性听力损失(SNHL)。对1953年至1995年间评估的134例患者病历进行仔细回顾,以寻找可能与抗生素相关的耳毒性,结果发现两名患者因在鼓膜穿孔情况下过量使用含新霉素和多粘菌素的耳滴剂而出现双侧严重SNHL。尽管耳局部用药制剂被广泛使用,但它们很少引起SNHL。作者强调患者教育、使用浸泡过的纱布条应用局部用耳滴剂,以及在治疗方案开始时记录患者的听力状况。

相似文献

1
Ototoxicity of ear drops: a clinical perspective.耳滴液的耳毒性:临床视角
Am J Otol. 1995 Sep;16(5):653-7.
2
Safety of ototopical antibiotics.
Laryngoscope. 1995 May;105(5 Pt 1):472-4. doi: 10.1288/00005537-199505000-00003.
3
Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.每日一次的氧氟沙星耳用溶液与每日四次的硫酸新霉素/硫酸多粘菌素B/氢化可的松耳用混悬液对比:一项多中心、随机、评估者盲法试验,比较小儿外耳道炎患者的疗效、安全性及疼痛缓解情况。
Curr Med Res Opin. 2006 Sep;22(9):1725-36. doi: 10.1185/030079906X121057.
4
Safety of topical ear drops containing ototoxic antibiotics.含耳毒性抗生素的外用耳滴剂的安全性。
J Otolaryngol. 1997 Jun;26(3):194-6.
5
Toxicity of ototopical drugs: animal modeling.
Ann Otol Rhinol Laryngol Suppl. 1990 Jun;148:42-5. doi: 10.1177/00034894900990s612.
6
Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.两项临床试验的汇总分析,比较了环丙沙星/地塞米松耳用混悬液与多粘菌素B/新霉素/氢化可的松耳用混悬液治疗成人和儿童急性外耳道炎的临床疗效。
Clin Ther. 2007 Sep;29(9):1950-6. doi: 10.1016/j.clinthera.2007.09.005.
7
Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.使用新霉素滴耳液后的耳毒性与线粒体DNA中的A1555G点突变无关。
J Laryngol Otol. 2004 Jul;118(7):546-50. doi: 10.1258/0022215041615245.
8
Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.外用环丙沙星/地塞米松与新霉素/多粘菌素B/氢化可的松治疗外耳道炎的疗效和安全性比较
Curr Med Res Opin. 2004 Aug;20(8):1175-83. doi: 10.1185/030079902125004312.
9
Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration.
Otolaryngol Head Neck Surg. 2006 Aug;135(2):291-4. doi: 10.1016/j.otohns.2006.03.009.
10
Ototoxicity of an ototopic preparation--experimental results and clinical facts.耳局部用药制剂的耳毒性——实验结果与临床事实
Acta Otorhinolaryngol Belg. 1991;45(3):279-82.

引用本文的文献

1
Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature.局部用抗生素滴耳液对人类慢性化脓性中耳炎的耳毒性:文献综述
Cureus. 2022 Dec 21;14(12):e32780. doi: 10.7759/cureus.32780. eCollection 2022 Dec.
2
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.临床药物遗传学实施联盟基于 MT-RNR1 基因型指导使用氨基糖苷类药物。
Clin Pharmacol Ther. 2022 Feb;111(2):366-372. doi: 10.1002/cpt.2309. Epub 2021 Jun 20.
3
Sensorineural hearing loss in patients with chronic otitis media.
慢性中耳炎患者的感音神经性听力损失
Eur Arch Otorhinolaryngol. 2009 Feb;266(2):221-4. doi: 10.1007/s00405-008-0739-0. Epub 2008 Jul 16.
4
A benefit-risk assessment of ofloxacin otic solution in ear infection.氧氟沙星耳用溶液治疗耳部感染的效益-风险评估
Drug Saf. 2003;26(6):405-20. doi: 10.2165/00002018-200326060-00003.
5
External Otitis: A Challenge in Management.外耳道炎:治疗中的一项挑战。
Curr Infect Dis Rep. 2000 Apr;2(2):160-167. doi: 10.1007/s11908-000-0029-5.
6
Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides.用于慢性中耳炎的喹诺酮类耳滴剂。它们比氨基糖苷类药物更安全、更有效。
BMJ. 2000 Jul 15;321(7254):126-7. doi: 10.1136/bmj.321.7254.126.
7
The use of eardrops in an ENT department.耳鼻喉科中耳滴剂的使用。
Pharm World Sci. 1999 Dec;21(6):266-9. doi: 10.1023/a:1008712422891.